Nomegestrol Acetate/EstradiolIn Oral Contraception

被引：0
|
作者：
Lily P. H. Yang
Greg L. Plosker
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Estradiol; Acne; Ethinylestradiol; Combine Oral Contraceptive; Contraceptive Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nomegestrol acetate/estradiol is a combined oral contraceptive with approval in many countries. This fixed-dose combination tablet contains nomegestrol acetate, a highly selective progestogen, and estradiol, a natural estrogen. It is the first monophasic combined oral contraceptive to contain estradiol, and is taken in 28-day cycles, consisting of 24 active therapy days with 4 placebo days (i.e. 24/4-day cycles).
引用
收藏
页码：1917 / 1928
页数：11
相关论文
共 50 条
  • [21] Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function
    Agren, Ulla M.
    Anttila, Marjatta
    Maenpaa-Liukko, Kristiina
    Rantala, Maija-Liisa
    Rautiainen, Hilkka
    Sommer, Werner F.
    Mommers, Ellen
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06) : 458 - 467
  • [22] Pharmacokinetics of depot medroxyprogesterone acetate contraception
    Mishell, DR
    JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (05) : 381 - 390
  • [23] Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative
    van Diepen, Harry A.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2012, 10
  • [24] Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen
    Mansour, Diana
    Verhoeven, Carole
    Sommer, Werner
    Weisberg, Edith
    Taneepanichskul, Surasak
    Melis, Gian Benedetto
    Sundstrom-Poromaa, Inger
    Korver, Tjeerd
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06) : 430 - 443
  • [25] Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC)
    Neri, Manuela
    Malune, Maria Elena
    Corda, Valentina
    Piras, Bruno
    Zedda, Pierina
    Pilloni, Monica
    Orani, Maria Paola
    Vallerino, Valerio
    Melis, Gian Benedetto
    Paoletti, Anna Maria
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (12) : 958 - 962
  • [26] Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
    Akintomide, Hannat
    Panicker, Sabeena
    OPEN ACCESS JOURNAL OF CONTRACEPTION, 2015, 6 : 77 - 86
  • [27] The use of oral nomegestrol acetate/estradiol in rapid and random start preparation of endometrium before office hysteroscopic polypectomies: A multicenter, prospective, randomized controlled trial
    Etrusco, Andrea
    Agrifoglio, Vittorio
    Chiantera, Vito
    D'Amato, Antonio
    Russo, Giuseppe
    Giannini, Andrea
    Riemma, Gaetano
    Pecorino, Basilio
    Ferrari, Federico
    Monti, Marco
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 299 : 213 - 218
  • [28] Recent Innovations in Oral Contraception
    Cremer, Miriam
    Phan-Weston, Scarlett
    Jacobs, Adam
    SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (02) : 140 - 146
  • [29] Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
    Christin-Maitre, S.
    Serfaty, D.
    Chabbert-Buffet, N.
    Ochsenbein, E.
    Chassard, D.
    Thomas, J. -L.
    HUMAN REPRODUCTION, 2011, 26 (06) : 1338 - 1347
  • [30] Toward a new concept of "natural balance" in oral estroprogestin contraception
    Chabbert-Buffet, Nathalie
    Gerris, Jan
    Jamin, Christian
    Lello, Stefano
    Lete, Inaki
    Lobo, Paloma
    Nappi, Rossella E.
    Pintiaux, Axelle
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (10) : 891 - 896
12345